NDC 46287-045 – Tadliq

Tadalafil 20 mg/5mL · Suspension · Oral

Human Prescription Drug

Product NDC46287-045

Product details

Brand name
Tadliq
Generic name
Tadalafil
Labeler
CMP Pharma, Inc.
Dosage form
Suspension
Route
Oral
Marketing category
NDA · NDA214522
Marketed since
August 30, 2022
Listing expires
December 31, 2026
Pharmacologic class
Phosphodiesterase 5 Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Tadliq →

Package NDC codes (1)

Package NDCDescriptionSince
46287-045-15150 mL in 1 BOTTLE (46287-045-15)Aug 30, 2022